4 results
The primary objective is to determine the safety, tolerability, dose-limiting toxicities (DLTs), and maximum tolerated dose (MTD)/recommended Phase 2 dose (RP2D) of BMS-986178 administered alone or in combination with nivolumab and/or ipilimumab in…
The main objective of this study is investigating whether augmented reality can provoke symptoms in patients with contamination-based OCD by evaluating how this AR HMD symptom provocation compares to a traditional symptom provocation.
The main objective of this study is to investigate whether body ownership directly influnces the perception of pain in individuals with BIID. The secondary outcome examines whether or not AR is also an effective tool for ameliorating physical and…
The main objective of this study is to investigate whether perspective (i.e. first person vs. third person) directly influences the interplay between body ownership and pain perception.